Avid Bioservices to Present at Upcoming Investor Conferences
August 29 2018 - 8:05AM
Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated
biologics contract development and manufacturing organization
(CDMO) working to improve patient lives by providing high quality
development and manufacturing services to biotechnology and
pharmaceutical companies, today announced that its president and
chief executive officer, Roger Lias, Ph.D., will deliver corporate
presentations at three upcoming investor conferences.
Details of these presentations are as
follows:
- 13th Annual Wells Fargo Securities Healthcare
Conference
Time/Date:
10:15 a.m. ET on Wednesday, September 5, 2018
Location:
The Westin Copley Place, Boston
Room:
St. George CD (3rd Floor)
- H.C. Wainwright 20th Annual Global Investment
Conference
Time/Date:
11:15 a.m. ET on Thursday, September 6, 2018 (webcast
available) Location:
St. Regis Hotel, New
York Room:
Library (2nd Floor)
- Janney Montgomery Scott 2018 Healthcare
Conference
Time/Date:
9:55 a.m. ET on Tuesday, September 18, 2018 (webcast
available) Location:
The Union League Club, New
York Room:
Chase
To access live webcasts of the H.C. Wainwright
and Janney Montgomery Scott presentations, please visit the
“Upcoming Events” page within the Investors section of the Avid
Bioservices website at: http://ir.avidbio.com/events.cfm.
Additionally, replays of the webcasts will be available on the Avid
website following the conferences.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract development
and manufacturing organization (CDMO) focused on development and
cGMP manufacturing of biopharmaceutical products derived from
mammalian cell culture. The company provides a comprehensive
range of process development, high quality cGMP clinical and
commercial manufacturing services for the biotechnology and
biopharmaceutical industries. With 25 years of experience
producing monoclonal antibodies and recombinant proteins in batch,
fed-batch and perfusion modes, Avid's services include cGMP
clinical and commercial product manufacturing, purification, bulk
packaging, stability testing and regulatory strategy, submission
and support. The company also provides a variety of process
development activities, including cell line development and
optimization, cell culture and feed optimization, analytical
methods development and product characterization.
www.avidbio.com
Contacts:Stephanie Diaz (Investors)Vida
Strategic Partners415-675-7401sdiaz@vidasp.com
Tim Brons (Media)Vida Strategic
Partners415-675-7402 tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Sep 2023 to Sep 2024